Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - December 18.03.2026 QDEC.LN IE000GAKWFA7 450,002.00 USD 10,105,267.50 22.456  ...

HAMILTON, Bermuda--(BUSINESS WIRE)--Signet Jewelers Limited ("Signet" or the "Company") (NYSE:SIG) today announced its results for the 13 and 52 weeks ended January 31, 2026 ("fourth quarter Fiscal 2026" and "full year Fiscal 2026", respectively). "FY26 delivered over a point of comp growth driven by heightened focus on our three largest brands – Kay, Zales, and Jared. Building on that momentum, FY27 will focus on accelerating core performance through sharper brand differentiation, broader cust...

CORVALLIS, Ore.--(BUSINESS WIRE)--NuScale & Ebara Elliott Energy partner to examine the development, demonstration and field testing of an industrial scale steam compressor using NPMs...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Europe Infrastructure UCITS ETF 18.03.2026 FTEI.LN IE000TIZ5AP4 150,002.00 EUR 3,021,953.91 20.146  ...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide), an androgen receptor pathway inhibitor (ARPI), in people with homologous recombination repair (HRR) gene-mutated metastatic castration-sensitive prostate cancer (mCSPC), also known as metastatic hormone-sensitive prostate cancer (mHSPC). The study m...

OMAHA, Neb.--(BUSINESS WIRE)--Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, today announced it plans to release financial results for its fiscal 2026 second quarter ended February 28, 2026, before the market opens on Thursday, April 2, 2026. Management, including Randy Wood, President and Chief Executive Officer, and Sam Hinrichsen, Senior Vice President and Chief Financial Officer, will host a conferenc...

PARAMUS, N.J.--(BUSINESS WIRE)--Movado Group, Inc. (NYSE: MOV) today announced fourth quarter and fiscal year 2026 results for the periods ended January 31, 2026. Fiscal Year 2026 Highlights (See attached table for GAAP and Non-GAAP measures) Net sales of $671.3 million compared to $653.4 million for fiscal year 2025; Operating income of $29.8 million compared to $20.0 million for fiscal year 2025; Adjusted operating income of $34.8 million compared to $27.1 million for fiscal year 2025; Dilute...

VODNJAN, Croatia--(BUSINESS WIRE)--AI-first cloud communication platform Infobip has released its Messaging Trends Report 2026....

ST. LOUIS--(BUSINESS WIRE)--Caleres (NYSE: CAL), a market-leading portfolio of consumer-driven footwear brands, today reported financial results for the fourth quarter and full year 2025, as well as guidance for first quarter and full year 2026. Reported fourth quarter net sales of $695.1 million, up 8.7%. Brand Portfolio sales increased 20.3%, with organic sales up 1.5%. Continued growth across all channels of our Brand Portfolio business, supplemented by continued market share gain in Women’s...